BOSTON, May 15, 2019 /PRNewswire/ -- Ginkgo Bioworks, the organism company, today announced it acquired the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines, Inc ...

Two papers in this issue present the results of large scale 'data mining' projects, in which the authors have used mouse genomic sequence databases to provide near-comprehensive descriptions of ...

Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio's genome mining platform and its antibiotics discovery deal with Roche. "This is a big part ...

Now that the draft human genome sequence is available, everyone wants to be able to use it. However, we have perhaps become complacent about our ability to turn new genomes into lists of genes.

Ginkgo Bioworks is buying Warp Drive Bio’s genome mining team, tech and database, eyeing the platform for use in next-generation antibiotics. Ginkgo has also taken on an antibiotics pact with ...

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate ...

ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers ...

Massive Autism Genome Database Finds Home on Google's Cloud. ... "We expect the total size of the completed database of 10,000 genomes along with all the associated clinical data to be on the ...